Israel’s MediWound signs $112 million deal in U.S. for burn treatment

  Clal Biotechnology Industries Ltd. reported to the Tel Aviv Stock Exchange Today that its wound and burn care solutions unit MediWound Ltd. has been awarded a $112 million contract by the US Biomedical More...